ÂÜÀòÂÒÂ×

Leah Fine spearheads LUNGevity’s early lung cancer initiatives and oversees both the strategy and operations of the Early Lung Cancer Center, combining LUNGevity’s research, advocacy, and education initiatives to create the greatest impact for patients.

Leah is a healthcare market strategy professional with expertise in oncology early detection, precision medicine, and multidisciplinary care. She earned a Bachelor of Science in biology and journalism from George Washington University and later earned her MBA from the Berkeley Haas School of Business. She has a background in nonprofit and for-profit settings, where she gained experience in business development, strategic marketing, and program development and implementation in the healthcare space. Leah comes to LUNGevity from GO2 For Lung Cancer, where she oversaw the Center of Excellence Program.